Cancer discovery news
Our researchers are making the discoveries that defeat cancer. Read the latest findings from our world-leading research.
Visit our main news hub to read about news on new funding, our fundraising activities and much more. If you want to keep updated on our news, you can follow us on social media or sign up for our Search newsletter.
If you’re a journalist and want to find out more, you can contact our media relations team.
Immuno-oncology collaboration to develop innovative new type of cancer drug
Scientists at The Institute of Cancer Research, London, are teaming up with small molecule neoantigen immuno-oncology company NeoPhore to develop new potential cancer drugs.
New study reveals key priorities to guide US President Biden’s Cancer Moonshot
Researchers have revealed a set of recommendations to help reach the US Cancer Moonshot’s target of cutting cancer deaths by half in the next 25 years.
.jpg?sfvrsn=b8be1e0b_2 "breast cancer cell 547x410 (1)")
ICR hails ‘momentous’ recommendation of olaparib for breast and prostate cancer
The Institute of Cancer Research, London, has hailed the ‘life-changing’ decision by NICE to recommend that the targeted drug olaparib can be used for NHS patients with both early-stage breast cancer and prostate cancer.
-547x410.jpg?sfvrsn=5e98f2c_2 "Clinical trials pharmacy (Jan Chlebik for the ICR, 2014) 547x410")
Innovative first in class HSF1 pathway cancer drug shows strong results in new study
A new, oral ‘first in class’ experimental cancer drug has shown potent activity against cancer cells and caused shrinkage of hard-to-treat human ovarian tumours grown in mice, a new study shows.
Biological markers identified as powerful predictors of prostate cancer relapse following radiotherapy
Two key proteins linked to cell division can reliably predict disease recurrence in prostate cancer after radiotherapy treatment, according to new research.
Cancer cells set to be launched into space for microgravity experiment on the International Space Station
A pioneering UK research project to study the three-dimensional spread of cancer cells in microgravity is set to take place on the International Space Station.
Genetic test can guide treatment for blood cancer to help prevent relapse
Scientists have found a new way to predict which patients with the blood cancer myeloma will benefit the most from a treatment often used to help keep the disease from coming back after a bone marrow transplant.
New scan measures tumour oxygen levels in real-time to help guide treatment
Imaging researchers have taken a major step towards their ultimate goal of identifying cancers that are starved of oxygen so that altered treatment can be used to target them more effectively.
Over a decade of abiraterone: the drug that revolutionised advanced prostate cancer care
This Prostate Cancer Awareness Month, we’re celebrating over 10 years since abiraterone was first recommended by NICE in England as a treatment for advanced prostate cancer. We share the story of the drug’s discovery, how a landmark trial changed the way advanced prostate cancer is treated today, and what the drug has meant for patients who are currently treated with it.
Charity funding could help establish new clinical trials for deadliest of all childhood cancers
The Institute of Cancer Research, London has been awarded £2.5 million by the charity Brain Tumour Research to help find new treatments and pave the way towards a cure for the childhood cancer high grade glioma, a type of brain tumour.
Scientists discover a new way to help prevent breast cancer ‘time bomb’
Scientists have discovered why breast cancer cells that have spread to the lungs may ‘wake up’ following years of sleep - forming incurable secondary tumours.
Algorithm offers new way to spot patients likely to respond to immunotherapy
Scientists have developed a new way of using cancers’ DNA to spot cancer patients who may benefit from immunotherapy.